Bone-targeting ZBTB16 overexpression had a therapeutic effect on the decreased bone density and remodeling capacity of Brd4fl/flPrx1-cre mice and osteoporosis (OP) models. This evidence concerns the gene ZBTB16 and osteoporosis.